In SCLC, the use of monoclonal anti-GD2 antibody 14G2a induces either anoïkis by dephosphorylation of FAK, or apoptosis by p38, c-Jun terminal kinase (JNK) and caspase-3 activtion [21,43,91]. Here, MAPK8 is linked to small cell lung carcinoma.